$3.87
-0.04[-1.02%]
At close: Apr 19
$3.87
0[0.00%]
After Hours: 6:29PM EDT
AbCellera Biologics
(NASDAQ:ABCL)AbCellera Biologics Stock (NASDAQ:ABCL), Earnings Estimates, EPS, and Revenue
AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$11M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$38M
Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | PM | ABCL | Q1 | -$0.14 | -$0.16 | — | — | $12.19M | $11.02M | — | — | Get Alert |
| 02/20/2024 | PM | ABCL | Q4 | -$0.10 | -$0.13 | -$0.16 | -23.08% | $21.55M | $8.88M | $9.18M | 3.37% | Get Alert |
| 11/02/2023 | PM | ABCL | Q3 | $0.08 | -$0.13 | -$0.10 | 23.08% | $101.38M | $11.90M | $6.60M | -44.55% | Get Alert |
| 08/03/2023 | PM | ABCL | Q2 | -$0.02 | -$0.13 | -$0.11 | 15.38% | $45.92M | $12.37M | $10.06M | -18.71% | Get Alert |
| 05/04/2023 | PM | ABCL | Q1 | $0.54 | -$0.14 | -$0.14 | 0.00% | $316.58M | $12.11M | $12.19M | 0.68% | Get Alert |
| 02/21/2023 | PM | ABCL | Q4 | $0.19 | $0.00 | -$0.10 | — | $139.33M | $50.80M | $21.55M | -57.59% | Get Alert |
| 11/08/2022 | PM | ABCL | Q3 | -$0.08 | $0.04 | $0.08 | 100.00% | $5.51M | $74.95M | $101.38M | 35.27% | Get Alert |
| 08/09/2022 | PM | ABCL | Q2 | -$0.01 | -$0.02 | -$0.02 | 0.00% | $27.64M | $53.59M | $45.92M | -14.32% | Get Alert |
| 05/10/2022 | PM | ABCL | Q1 | $0.37 | $0.33 | $0.54 | 63.64% | $202.74M | $194.67M | $316.58M | 62.62% | Get Alert |
| 02/24/2022 | PM | ABCL | Q4 | $0.44 | $0.19 | $0.19 | 0.00% | $207.91M | $122.05M | $139.33M | 14.16% | Get Alert |
| 11/09/2021 | PM | ABCL | Q3 | -$0.02 | — | -$0.08 | — | $9.36M | — | $5.51M | — | Get Alert |
| 08/12/2021 | PM | ABCL | Q2 | — | $0.11 | -$0.01 | -109.09% | — | $87.32M | $27.64M | -68.34% | Get Alert |
| 05/13/2021 | PM | ABCL | Q1 | — | $0.38 | $0.37 | -2.63% | — | $196.48M | $202.74M | 3.19% | Get Alert |
FAQ
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics (ABCL) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 20, 2024 for Q4.
What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?
The Actual EPS was $-0.16, which missed the estimate of $-0.13.
What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?
The Actual Revenue was $9.2M, which beat the estimate of $8.9M.
Browse earnings estimates, EPS, and revenue on all stocks.